Holen Sie sich die Stockscreener-App
73.53
0.30%
-0.035
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$73.56
Offen:
$73.5
24-Stunden-Volumen:
1.01M
Relative Volume:
0.17
Marktkapitalisierung:
$30.38B
Einnahmen:
$9.51B
Nettoeinkommen (Verlust:
$2.64B
KGV:
12.18
EPS:
6.0361
Netto-Cashflow:
$2.14B
1W Leistung:
-3.72%
1M Leistung:
+0.94%
6M Leistung:
-40.06%
1J Leistung:
-51.04%
1-Tages-Spanne:
$73.22
$74.08
1-Wochen-Bereich:
$73.22
$78.00
52-Wochen-Spanne:
$71.00
$152.00
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, TEVA, HLN, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
73.52 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
18.29 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.86 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.165 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
497.22 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
Zoetis (ZTS) Shares Drop After Earnings Revision - Yahoo Finance
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Is Zoetis Stock Underperforming the S&P 500? - Yahoo Finance
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - BioSpace
Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package - ChartMill
Zoetis Inc. (ZTS) - DirectorsTalk Interviews
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Is It Too Late to Buy Zoetis Inc (ZTS) After 3.1% Rally? GF Value Says Undervalued - GuruFocus
A Look at Zoetis Inc (ZTS) After 3.2% Decline -- GF Value $180.6 - GuruFocus
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Bull Case For Zoetis (ZTS) Could Change Following FDA Emergency Use Authorization For Simparica Trio - simplywall.st
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? - Yahoo Finance
MS Global Franchise Portfolio's Bold Q2 2026 Move: Exits Zoetis Inc, a -2.6% Portfolio Impact - Yahoo Finance
Zoetis Inc. $ZTS Shares Acquired by Wealthfront Advisers LLC - MarketBeat
Zoetis Updates Prescribing Information for FACTREL Cattle Injection - geneonline.com
ZTS Maintained by Stifel -- Price Target Lowered to $80 - GuruFocus
Stifel Nicolaus Has Lowered Expectations for Zoetis (NYSE:ZTS) Stock Price - MarketBeat
Stifel cuts Zoetis stock price target on key franchise weakness - Investing.com
Stifel cuts Zoetis stock price target on key franchise weakness By Investing.com - Investing.com India
Meeder Asset Management Inc. Sells 42,497 Shares of Zoetis Inc. $ZTS - MarketBeat
Flossbach Von Storch SE Buys Shares of 4,210,978 Zoetis Inc. $ZTS - MarketBeat
Tranche Update on Zoetis Inc.'s Equity Buyback Plan announced on August 1, 2024. - marketscreener.com
Zoetis Inc (ZTS) Shares Surge 3.7% -- What GF Score of 64 Tells Investors - GuruFocus
Zoetis Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Zoetis appoints Jay Saccaro as CFO and COO - WATTPoultry.com
Zoetis (ZTS) Stock Still Looks Cheap After a 62% Slide - Yahoo Finance
Is Zoetis’ Lowered 2026 Outlook and Simparica Trio EUA Altering The Investment Case For Zoetis (ZTS)? - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Has $76.91 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Main Street Financial Solutions LLC Makes New Investment in Zoetis Inc. $ZTS - MarketBeat
How a new AI value framework and stakeholder focus keep Zoetis ahead of the pack - cio.com
BlackRock Inc. Grows Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc (MIL:1ZTS) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA - simplywall.st
iShares Disciplined Volatility Equity Active ETF's Zoetis Inc(ZTS) Holding History - GuruFocus
Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy? - Yahoo Finance
Zoetis Inc. $ZTS Shares Bought by Texas Capital Bank Wealth Management Services Inc - MarketBeat
Deutsche Bank AG Purchases 319,709 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis’ pain therapy Portela receives VMD approval - Vet Times
Zoetis: A Solid Long-Term Buy After Harsh Drawdown (NYSE:ZTS) - Seeking Alpha
18,470 Shares in Zoetis Inc. $ZTS Purchased by GSA Capital Partners LLP - MarketBeat
Flputnam Investment Management Co. Raises Stock Position in Zoetis Inc. $ZTS - MarketBeat
ZTS Shareholders Have Opportunity to Lead Zoetis Inc. Class Actio - The National Law Review
Zoetis Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zoetis stock hits 52-week low at 71.41 USD - Investing.com
Zoetis (NYSE:ZTS) Hits New 52-Week LowHere's Why - MarketBeat
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
GE HealthCare CFO Jay Saccaro Leaves for Expanded Role at Zoetis - The Healthcare Technology Report.
Zoetis Inc. (ZTS) Stock Analysis: Potential 36.79% Upside Amid Healthcare Sector Dynamics - DirectorsTalk Interviews
Diamond Hill Capital Management LLC Investment Advisor Purchases 629,974 Shares of Zoetis Inc. $ZTS - MarketBeat
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):